{
    "id": "625374a8e764a53204000027",
    "question": "Is periampullary carcinoma (PAC) a relatively rare genitourinary malignancy",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "B",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, let's analyze the given documents and look for information about periampullary carcinoma (PAC). Periampullary carcinoma is a type of cancer that occurs at the junction of the bile and pancreatic ducts in the duodenum. According to Document [0], ampullary and periampullary cancers need to be distinguished from each other, and periampullary cancer includes tumors arising from the distal bile duct, duodenal mucosa, or pancreas just adjacent to the ampulla. This implies that periampullary carcinoma is not a genitourinary malignancy but rather a type of cancer related to the biliary and pancreatic systems. Therefore, it is unlikely to be a genitourinary malignancy. Let's look for more information about genitourinary malignancies in the provided documents. According to Document [12], genitourinary malignancies include bladder, kidney, and testicular cancers, but not periampullary carcinoma. This further supports the conclusion that periampullary carcinoma is not a genitourinary malignancy. Based on the information provided, the answer to the question is that periampullary carcinoma (PAC) is not a relatively rare genitourinary malignancy.\", \"answer_choice\": \"A\"}",
    "snippets": [
        {
            "id": "Surgery_Schwartz_9873",
            "title": "Surgery_Schwartz",
            "content": "resection or when a rising CA19-9 or new symptoms suggest recurrence. Surgical therapy for recurrent disease is usually reserved only for select patients with lim-ited disease who remain reasonable operative candidates who develop symptomatic gastric outlet or bowel obstruction.Ampullary and Periampullary Cancer. Ampullary cancers need to be distinguished from periampullary cancers. The ampulla is the junction of the biliary and pancreatic ducts within the duodenum. Periampullary cancer includes tumors arising from the distal bile duct, duodenal mucosa, or pancreas just adjacent to the ampulla, and the ampulla can be overgrown by cancers that arise from these adjacent areas, making it impos-sible to determine the true site of origin. Clinically, the term periampullary cancer is, therefore, a nonspecific term used to refer to a variety of tumors arising at the intersection of these four sites. The term ampullary cancer is more specific and is reserved for tumors that arise at the"
        },
        {
            "id": "InternalMed_Harrison_7729",
            "title": "InternalMed_Harrison",
            "content": "Patients who present with liver, brain, and adrenal metastatic disease usually have a poor prognosis. Patients with nonserous papillary primary peritoneal carcinomatosis can have a large differential diagnosis, which is mainly of gastrointestinal profile and includes gastric, appendiceal, colon, and pancreaticobiliary profiles. Traditionally, platinum-based combination chemotherapy regimens have been used to treat CUP. Several broadly used regimens have been studied in the last two decades; these include paclitaxelcarboplatin, gemcitabine-cisplatin, gemcitabine-oxaliplatin, and irinotecan and fluoropyrimidine-based therapies. These chemotherapeutic agents used as empiric regimens have shown a response rate of 25\u201340%, and their use obtains median survival times of 6\u201313 months."
        },
        {
            "id": "Gynecology_Novak_7835",
            "title": "Gynecology_Novak",
            "content": "and is an invasive cancer characterized by foci of necrosis that exude a comedonecrosis-like substance when biopsied. Usually, comedocarcinomas are in situ malignancies. Papillary carcinoma is predominantly a noninvasive ductal carcinoma; when invasive components are present, it should be specified as invasive papillary carcinoma. Tubular carcinoma, a well-differentiated breast cancer that accounts for 1% to 2% of all malignant breast neoplasms, rarely metastasizes to axillary lymph nodes and tends to have a better prognosis than infiltrating ductal carcinoma. Adenoid cystic carcinomas are extremely rare breast tumors that histologically are similar to those seen in the salivary glands. They are well-differentiated cancers that are slow to metastasize."
        },
        {
            "id": "Gynecology_Novak_7834",
            "title": "Gynecology_Novak",
            "content": "Special types of infiltrating ductal carcinoma are uncommon and typically account for nearly 10% of all invasive cancers. Medullary carcinoma, which accounts for 5% to 8% of breast carcinomas, arises from larger ducts within the breast and has a dense lymphocytic infiltrate. The tumor appears to be a slower growing and less-aggressive malignancy than other forms of carcinoma. Even when axillary disease is present, the prognosis with medullary carcinoma is better than that of other variants of invasive ductal carcinoma. Mucinous (colloid) carcinoma accounts for 5% of all breast cancers. Grossly, areas of the tumor may appear mucinous or gelatinous, whereas microscopically they are relatively acellular. Infiltrating comedo carcinoma accounts for less than 1% of all breast malignancies and is an invasive cancer characterized by foci of necrosis that exude a comedonecrosis-like substance when biopsied. Usually, comedocarcinomas are in situ malignancies. Papillary carcinoma is"
        },
        {
            "id": "Surgery_Schwartz_9794",
            "title": "Surgery_Schwartz",
            "content": "therefore, less commonly resectable. Tumors in the head of the pancreas are typically diagnosed earlier because they cause obstructive jaundice. Ampullary carci-nomas, carcinomas of the distal bile duct, and periampullary duodenal adenocarcinomas present in a similar fashion to pan-creatic head cancer but have a slightly better prognosis, prob-ably because early obstruction of the bile duct and jaundice leads to the diagnosis.In addition to ductal adenocarcinoma, which makes up about 75% of nonendocrine cancers of the pancreas, there are a variety of less common types of pancreatic cancer. Adenosquamous carcinoma is a variant that has both glandular and squamous differentiation. The biologic behavior of this lesion is unfortunately no better than the typical ductal adenocarcinoma.314 Acinar cell carcinoma is an uncommon type of pancreatic cancer that usually presents as a large tumor, often 10 cm in diameter or more, but the prognosis of patients with these tumors may be better than"
        },
        {
            "id": "InternalMed_Harrison_7379",
            "title": "InternalMed_Harrison",
            "content": "Renal cell neoplasia represents a heterogeneous group of tumors with distinct histopathologic, genetic, and clinical features ranging from benign to high-grade malignant (Table 114-3). They are classified on the basis of morphology and histology. Categories include clear cell carcinoma (60% of cases), papillary tumors (5\u201315%), chromophobe tumors (5\u201310%), oncocytomas (5\u201310%), and collecting or Bellini duct tumors (<1%). Papillary tumors tend to be bilateral and multifocal. Chromophobe tumors have a more indolent clinical course, and oncocytomas are considered benign neoplasms. In contrast, Bellini duct carcinomas, which are thought to arise from the collecting ducts within the renal medulla, are rare but often very aggressive. Clear cell tumors, the predominant histology, are found in >80% of patients who Carcinoma Growth Type Pattern Cell of Origin Cytogenetics Clear cell Acinar or Proximal tubule 3p-, 5q+, 14qsarcomatoid"
        },
        {
            "id": "Pathology_Robbins_4106",
            "title": "Pathology_Robbins",
            "content": "In contrast with mucinous cystic neoplasms, intraductal papillary mucinous neoplasms (IPMNs) occur more frequently in men than in women and more frequently involve the head of the pancreas. IPMNs arise in the main pancre-atic ducts, or one of its major branch ducts, and lack the cellular stroma seen in mucinous cystic neoplasms ( Fig."
        },
        {
            "id": "InternalMed_Harrison_3273",
            "title": "InternalMed_Harrison",
            "content": "Causes of extrahepatic cholestasis can be split into malignant and benign (Table 58-3). Malignant causes include pancreatic, gallbladder, and ampullary cancers as well as cholangiocarcinoma. This last malignancy is most commonly associated with PSC and is exceptionally difficult to diagnose because its appearance is often identical to that of PSC. Pancreatic and gallbladder tumors as well as cholangiocarcinoma are rarely resectable and have poor prognoses. Ampullary carcinoma has the highest surgical cure rate of all the tumors that present as painless jaundice. Hilar lymphadenopathy due to metastases from other cancers may cause obstruction of the extrahepatic biliary tree."
        },
        {
            "id": "Surgery_Schwartz_8209",
            "title": "Surgery_Schwartz",
            "content": "disease.Although the clinical presentation is usually not specific for tumor type, some general comments are appropriate. Adeno-carcinomas, as well as adenomas (from which most are believed to arise), are most commonly found in the duodenum, except in patients with Crohn\u2019s disease, in whom most are found in the ileum. Lesions in the periampullary location can cause obstruc-tive jaundice or pancreatitis. Adenocarcinomas located in the duodenum tend to be diagnosed earlier in their progression than those located in the jejunum or ileum, which are rarely diagnosed prior to the onset of locally advanced or metastatic disease.Carcinoid tumors of the small intestine are also usually diagnosed after the development of metastatic disease. These tumors are associated with a more aggressive behavior than the more common appendiceal carcinoid tumors. Approximately 25% to 50% of patients with carcinoid tumor-derived liver metastases will develop manifestations of the carcinoid syn-drome. These"
        },
        {
            "id": "Surgery_Schwartz_9877",
            "title": "Surgery_Schwartz",
            "content": "a locally excised tumor reveals invasive cancer, the patient should be returned to the operat-ing room for a pancreaticoduodenectomy. An important sub-set of patients are those with FAP who develop periampullary or duodenal adenomas. These lesions have a high incidence of harboring carcinoma and frequently recur unless the mucosa at risk is resected. A standard (not pylorus-sparing) Whipple is the procedure of choice in FAP patients with periampullary lesions.Cystic Neoplasms of the Pancreas. A cystic neoplasm needs to be considered when a patient presents with a fluid-containing pancreatic lesion. Asymptomatic cystic neoplasms of the pancreas may be more frequent than previously recognized and are being identified with increasing frequency as the use of abdominal CT scanning and MRI has increased. Pancreatic cysts are now thought to be present in about 9% of the popula-tion age 80 and older.371 When symptoms are clearly attributable to a pancreatic cyst, resection is indicated in"
        },
        {
            "id": "InternalMed_Harrison_7725",
            "title": "InternalMed_Harrison",
            "content": "FIGURE 120e-3 Treatment algorithm for squamous cell carcinoma of unknown primary (CUP). C, chemotherapy; CT, computed tomography; PET, positron emission tomography; RT, radiation. retrospective study of 258 women with peritoneal carcinomatosis who had undergone cytoreductive surgery and chemotherapy, 22% of patients had a complete response to chemotherapy; the median survival duration was 18 months (range 11\u201324 months). However, not all peritoneal carcinomatosis in women is PPSC. Careful pathologic evaluation can help diagnose a colon cancer profile (CDX-2+, CK-20+, CK7\u2212) or a pancreaticobiliary cancer or even a mislabeled peritoneal mesothelioma (calretinin positive)."
        },
        {
            "id": "Surgery_Schwartz_3630",
            "title": "Surgery_Schwartz",
            "content": "53519/02/19 3:09 PM 536SPECIFIC CONSIDERATIONSPART IIof choice for localized disease, but the rate of recurrence is high. Adjuvant radiation therapy can be considered in a multidisci-plinary fashion. Cases of extremity disease can be considered for amputation. For widely metastatic disease, chemotherapy and radiation may provide palliation, but these modalities do not prolong overall survival.115Extramammary Paget\u2019s DiseaseThis rare adenocarcinoma of apocrine glands arises in axillary, perianal, and genital regions of men and women.184 Clinical pre-sentation is that of erythematous or nonpigmented plaques with an eczema-like appearance that often persist after failed treat-ment from other therapies. An important characteristic and one that the surgeon must be acutely aware of is the high incidence of concomitant other malignancies with this cutaneous disease. Forty percent of cases are associated with primary gastrointesti-nal and genitourinary malignancies, and a diligent search"
        },
        {
            "id": "Pathology_Robbins_4124",
            "title": "Pathology_Robbins",
            "content": "Tanaka M, et al: International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas, Pancreatology 12:183\u2013 197, 2012. [An update to the 2006 consensus guidelines on how to identify the presence of malignancy within cystic precursor lesions of pancreatic cancer using imaging and other diagnostic criteria. Although not definitive, these guidelines are widely used for deciding which cyst patients require surgery versus observation.] http://ebooksmedicine.net studentconsult.com Scrotum,Testis,andEpididymis Ureter,Bladder,andUrethra"
        },
        {
            "id": "InternalMed_Harrison_7722",
            "title": "InternalMed_Harrison",
            "content": "The term primary peritoneal papillary serous carcinoma (PPSC) has been used to describe CUP with carcinomatosis with the pathologic and laboratory (elevated CA-125 antigen) characteristics of ovarian cancer but no ovarian primary tumor identified on transvaginal sonography or laparotomy. Studies suggest that ovarian cancer and PPSC, which are both of m\u00fcllerian origin, have similar gene expression profiles. Similar to patients with ovarian cancer, patients with PPSC are candidates for cytoreductive surgery, followed by adjuvant taxaneand platinum-based chemotherapy. In one Chapter 120e Carcinoma of Unknown Primary"
        },
        {
            "id": "Surgery_Schwartz_7524",
            "title": "Surgery_Schwartz",
            "content": "is adeno-carcinoma (95%); lymphoma and GIST account for most of the remaining cases (Table 26-14). Other rare primary malignancies include neuroendocrine tumor, angiosarcoma, carcinosarcoma, and squamous cell carcinoma. Occasionally the stomach is a site of hematogenous metastasis from other sites (e.g., melanoma or breast cancer). Malignant tumors from adjacent organs may also invade the stomach by direct extension (e.g., colon or pancreas) or by peritoneal dissemination (e.g., ovary or appendiceal).AdenocarcinomaEpidemiology. Gastric cancer is the fourth most common can-cer type and the second leading cause of cancer death world-wide. Over the past century, there has been a dramatic decrease in the incidence of gastric cancer in most Western industrialized countries (Fig. 26-49). This decrease has been largely in the so-called intestinal form rather than in the diffuse form of gastric cancer. In Asia and Eastern Europe, gastric cancer remains a leading cause of cancer death. In 2017"
        },
        {
            "id": "InternalMed_Harrison_7380",
            "title": "InternalMed_Harrison",
            "content": "Carcinoma Growth Type Pattern Cell of Origin Cytogenetics Clear cell Acinar or Proximal tubule 3p-, 5q+, 14qsarcomatoid Papillary Papillary or Proximal tubule +7, +17, -Y sarcomatoid"
        },
        {
            "id": "Surgery_Schwartz_9893",
            "title": "Surgery_Schwartz",
            "content": "with an associated invasive carcinoma, prognosis depends on the extent of the invasive component, tumor stage, and resectability. The 2-year survival rate and 5-year survival rate of patients with Brunicardi_Ch33_p1429-p1516.indd 150101/03/19 6:46 PM 1502SPECIFIC CONSIDERATIONSPART IIresected MCN with an associated invasive carcinoma are about 67% and 50%, respectively.375Intraductal Papillary Mucinous Neoplasm. Intraductal papillary mucinous neoplasms (IPMNs) usually occur within the head of the pancreas and arise within the pancreatic ducts. The ductal epithelium forms a papillary projection into the duct, and mucin production causes intraluminal cystic dilation of the pancreatic ducts (Fig. 33-79). Imaging studies demonstrate diffuse dilation of the pancreatic duct, and the pancreatic parenchyma is often atrophic due to chronic duct obstruction. However, classic features of chronic pancreatitis, such as calcification and a beaded appearance of the duct, are not present. At"
        },
        {
            "id": "Gynecology_Novak_7170",
            "title": "Gynecology_Novak",
            "content": "Serous Carcinomas In malignant serous tumors, stromal invasion is present (2). The grade of tumor is important and needs to be documented. In low-grade serous adenocarcinomas, papillary and glandular structures predominate (Fig. 37.3); high-grade neoplasms are characterized by solid sheets of cells, nuclear pleomorphism, and high mitotic activity (Fig. 37.4). Laminated, calcified psammoma bodies are found in 80% of serous carcinomas. Serous psammocarcinoma is a rare variant of serous carcinoma characterized by massive psammoma body formation and low-grade cytological features. At least 75% of the epithelial nests are associated with psammoma body formation. Patients with serous psammocarcinoma have a protracted clinical course and a relatively favorable prognosis; their clinical course more closely resembles that of high-stage, progressive serous borderline tumor than serous carcinoma."
        },
        {
            "id": "InternalMed_Harrison_7700",
            "title": "InternalMed_Harrison",
            "content": "Carcinoma of Unknown primary Gauri R. Varadhachary, James L. Abbruzzese Carcinoma of unknown primary (CUP) is a biopsy-proven malig-nancy for which the anatomic site of origin remains unidentified after 120e an intensive search. CUP is one of the 10 most frequently diagnosed cancers worldwide, accounting for 3\u20135% of all cancers. Most investigators limit CUP to epithelial cancers and do not include lymphomas, metastatic melanomas, and metastatic sarcomas because these cancers have specific histologyand stage-based treatments that guide management."
        },
        {
            "id": "InternalMed_Harrison_27014",
            "title": "InternalMed_Harrison",
            "content": "Adrenocortical carcinoma (ACC) is a rare malignancy with an annual incidence of 1\u20132 per million population. ACC is generally considered a highly malignant tumor; however, it presents with broad interindividual variability with regard to biologic characteristics and clinical behavior. Somatic mutations in the tumor-suppressor gene TP53 are found in 25% of apparently sporadic ACC. Germline TP53 mutations are the cause of the Li-Fraumeni syndrome associated with multiple solid organ cancers including ACC and are found in 25% of pediatric Disorders of the Adrenal Cortex 24-h urine for free cortisol excretion, plasma ACTH, midnight plasma (or salivary) cortisol, dexamethasone 1 mg overnight test (perform at least two out of four tests) If tumor >2 cm: Serum 17-hydroxyprogesterone and DHEAS imaging suggestive of malignancy: \u2022 Size >4 cm Negative and imaging not suggestive of malignancy: Neg. Pos. Neg. Pos."
        },
        {
            "id": "Pathology_Robbins_5270",
            "title": "Pathology_Robbins",
            "content": "Fig. 24.17 Basalcellcarcinoma.(A)Aprototypicalpearly,smooth-surfacedpapulewithtelangiectaticvessels.(B)Tumoriscomposedofnestsofbasaloidcellsinfiltratingafibroticstroma.(C)Tumorcellswithscantcytoplasmandsmallhyperchromaticnucleithatpalisadeontheoutsideofthenest.Thecleftbetweenthetumorcellsandthestromaisahighlycharacteristicartifactofsectioning. The incidence of both basal cell and squamous cell carcinomais strongly correlated with increasing lifetime sun exposure. Risk factors for cutaneous squamous cell carcinoma includefair skin, UV light exposure, exposure to carcinogenic chemicals, chronic skin inflammation and scarring, and HPV infection(in the setting of immunosuppression). Cutaneous squamous cell carcinoma has the potential for metastasis but usually is recognized and excised before it does so. Basal cell carcinoma, the most common malignancy worldwide, is a locally aggressive tumor associated with mutations in theHedgehog pathway. Metastasis is very rare."
        },
        {
            "id": "Gynecology_Novak_5555",
            "title": "Gynecology_Novak",
            "content": "Table 31.8 Causes of Cushing Syndrome ACTH, adrenocorticotropic hormone; CRH, corticotropin-releasing hormone. ACTH-dependent Cushing syndrome may be caused by pituitary adenoma, basophil hyperplasia, nodular adrenal hyperplasia, or cyclic Cushing syndrome. normal gland, the diurnal pattern of cortisol secretion is lost. Ectopic ACTH syndrome most often is caused by malignant tumors (155). About one-half of these tumors are small-cell carcinomas of the lung (156). Other tumors include bronchial and thymic carcinomas, carcinoid tumors of the pancreas, and medullary carcinoma of the thyroid. Ectopic corticotropin-releasing hormone (CRH) tumors are rare and include such tumors as bronchial carcinoids, medullary thyroid carcinoma, and metastatic prostatic carcinoma (156). The presence of an ectopic CRH-secreting tumor should be suspected in patients whose dynamic testing suggests pituitary ACTH-dependent disease but who have rapid disease progression and very high plasma ACTH levels."
        },
        {
            "id": "InternalMed_Harrison_7023",
            "title": "InternalMed_Harrison",
            "content": "Tumor spread to regional lymph nodes Number of regional lymph nodes involved Tumor penetration through the bowel wall Poorly differentiated histology Perforation Tumor adherence to adjacent organs Venous invasion Preoperative elevation of CEA titer (>5 ng/mL) Aneuploidy Specific chromosomal deletion (e.g., mutation in the b-raf gene) Abbreviation: CEA, carcinoembryonic antigen. venous plexus, escaping the portal venous system and thereby reaching the lungs or supraclavicular lymph nodes without hepatic involvement. The median survival after the detection of distant metastases has ranged in the past from 6\u20139 months (hepatomegaly, abnormal liver chemistries) to 24\u201330 months (small liver nodule initially identified by elevated CEA level and subsequent CT scan), but effective systemic therapy is significantly improving this prognosis."
        },
        {
            "id": "InternalMed_Harrison_7125",
            "title": "InternalMed_Harrison",
            "content": "most typically presents as painless jaundice, often with pruritus or weight loss. Diagnosis is made by biopsy, percutaneously for peripheral liver lesions, or more commonly via endoscopic retrograde cholangiopancreatography (ERCP) under direct vision for central lesions. The tumors often stain positively for cytokeratins 7, 8, and 19 and negatively for cytokeratin 20. However, histology alone cannot usually distinguish CCC from metastases from colon or pancreas primary tumors. Serologic tumor markers appear to be nonspecific, but CEA, CA 19-9, and CA-125 are often elevated in CCC patients and are useful for following response to therapy. Radiologic evaluation typically starts with ultrasound, which is very useful in visualizing dilated bile ducts, and then proceeds with either MRI or magnetic resonance cholangiopancreatography (MRCP) or helical CT scans. Invasive cholangiopancreatography (ERCP) is then needed to define the biliary tree and obtain a biopsy or is needed therapeutically"
        },
        {
            "id": "Gynecology_Novak_7177",
            "title": "Gynecology_Novak",
            "content": "Borderline Brenner Tumors In the past, proliferative Brenner tumors were subclassified as proliferating tumors (those tumors that resemble low-grade papillary urothelial carcinoma of the urinary bladder) and borderline tumors (those tumors that resemble high-grade papillary urothelial carcinoma), but both groups of tumors are now classified as borderline Brenner tumors (21). Complete surgical removal usually results in cure. Malignant Brenner Tumors These rare tumors are defined as benign or borderline Brenner tumors coexisting with invasive transitional cell carcinoma. Figure 37.7 Clear cell carcinoma of the ovary. Note the solid variant of clear cell carcinoma with sheets of cells that have clear cytoplasm (\u201chobnail\u201d cells)."
        },
        {
            "id": "Pathology_Robbins_4109",
            "title": "Pathology_Robbins",
            "content": "http://ebooksmedicine.net Like all cancers, pancreatic cancer arises as a consequence of inherited and acquired mutations in cancer-associated Fig. 17.7 Intraductal papillary mucinous neoplasm. (A) Cross-section through the head of the pancreas showing a prominent papillary neoplasm distending the main pancreatic duct. (B) The papillary mucinous neoplasm involves the main pancreatic duct (left) and is extending down into the smaller ducts and ductules (right). genes. In a pattern analogous to that seen in the multi-step progression of colon cancer (Chapter 6), there is a progressive accumulation of genetic changes in pancreatic epithelium as it proceeds from nonneoplastic, to noninvasive precursor lesions, to invasive carcinoma ("
        },
        {
            "id": "Surgery_Schwartz_2159",
            "title": "Surgery_Schwartz",
            "content": "systemic therapy choices for breast cancer. Some targeted therapies are showing activity in BRCA mutation carriers with breast cancer such as PARP poly(ADP-ribose) polymerase-inhibitors.APC Gene and Familial Adenomatous PolyposisPatients affected with familial adenomatous polyposis (FAP) characteristically develop hundreds to thousands of polyps in the colon and rectum. The polyps usually appear in adolescence and, if left untreated, progress to colorectal cancer. FAP is asso-ciated with benign extracolonic manifestations that may be use-ful in identifying new cases, including congenital hypertrophy of the retinal pigment epithelium, epidermoid cysts, and osteo-mas. In addition to colorectal cancer, patients with FAP are at risk for upper intestinal neoplasms (gastric and duodenal pol-yps, duodenal and periampullary cancer), hepatobiliary tumors (hepatoblastoma, pancreatic cancer, and cholangiocarcinoma), thyroid carcinomas, desmoid tumors, and medulloblastomas.The product of the"
        },
        {
            "id": "Gynecology_Novak_7904",
            "title": "Gynecology_Novak",
            "content": "The overall prognosis for patients with this rare form of breast cancer depends on the stage of the underlying malignancy. When an intraductal carcinoma alone is identified, the prognosis remains favorable, whereas patients with infiltrating ductal carcinoma metastatic to the regional lymph nodes have worse outcomes. Traditional treatment was total mastectomy and lymph node dissection, although breast conservation therapy with resection of the tumor and nipple\u2013areolar complex, followed by whole breast radiation, is being performed in appropriately identified patients (122)."
        },
        {
            "id": "Surgery_Schwartz_9885",
            "title": "Surgery_Schwartz",
            "content": "identified during imaging performed for other reasons. When symptoms are present, they are usually nonspecific and include upper abdominal discomfort or pain, early satiety, and weight loss. On imaging studies, the cysts have thick walls and do not communicate with the main pancreatic duct (Fig. 33-78). There may be nodules or calcifications within the wall of the cyst. The cysts are lined by tall columnar epithelium that fills the cyst with viscous mucin. The submucosal layer consists of a highly cellular stroma of spindle cells with elongated nuclei similar to the \u201covarian stroma,\u201d which is a key pathologic feature distinguishing these lesions. Elevated CEA levels in the fluid (\u2265200 ng/mL) are consistent with mucinous lesions and may suggest malignant transformation.373 Solid areas may con-tain atypical cells or invasive cancer, and extensive sampling of the specimen is necessary to accurately predict prognosis. Figure 33-77. Mucinous cystic neoplasm in tail of pancreas.Table"
        },
        {
            "id": "Surgery_Schwartz_9798",
            "title": "Surgery_Schwartz",
            "content": "Topo\u02dc\u02dc\u00b0, 14-3-3\u02dbp53, DPC4, BRCA2Cyclin D1MesothelinMucin 1Mucin 1p16PSCA, Mucin5, FascinTelomere K-rasshorteningPanIN-3InvasionABCDFigure 33-67. Pancreatic intraepithelial neoplasia (PanIN). Histology (top panel) showing grades PanIN-1A (A), PanIN-1B (B), PanIN-2 (C), and PanIN-3 (D), and schema of correlation of histology with mutational events (bottom panel) showing cumulative abnormalities of tumor-promoter and tumor suppressor factors such as kRAS, p53, etc, and their corresponding cellular phenotype. (Reproduced with permis-sion from Hruban RH, Takaori K, Klimstra DS, et al: An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms, Am J Surg Pathol. 2004 Aug;28(8):977-987.)The most critical deficit in the ability to treat pancreatic cancer effectively is the lack of tools for early diagnosis. The pancreas is situated deep within the abdomen, and the early symptoms of pancreatic cancer often are too"
        },
        {
            "id": "InternalMed_Harrison_21287",
            "title": "InternalMed_Harrison",
            "content": "This common clinical problem can be caused by a primary carcinoma arising in the pancreas, ampulla of Vater, bile duct, or liver or by metastatic disease to the periductal lymph nodes or liver parenchyma. The most common metastatic tumors causing biliary obstruction are gastric, colon, breast, and lung cancers. Jaundice, light-colored stools, dark urine, pruritus, and weight loss due to malabsorption are usual symptoms. Pain and secondary infection are uncommon in malignant biliary obstruction. Ultrasound, CT scan, or percutaneous transhepatic or endoscopic retrograde cholangiography will identify the site and nature of the biliary obstruction."
        },
        {
            "id": "InternalMed_Harrison_27146",
            "title": "InternalMed_Harrison",
            "content": "MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 AND TYPE 3 Clinical Manifestations MEN type 2 (MEN 2), which is also called Sipple\u2019s syndrome, is characterized by the association of medullary thyroid carcinoma (MTC), pheochromocytomas, and parathyroid tumors (Table 408-1). Three clinical variants of MEN 2 are recognized: MEN 2A, MEN 2B, and MTC only. MEN 2A, which is often referred to as MEN 2, is the most common variant. In MEN 2A, MTC is associated with pheochromocytomas in 50% of patients (may be bilateral) and with parathyroid tumors in 20% of patients. MEN 2A may rarely occur in association with Hirschsprung\u2019s disease, caused by the absence of autonomic ganglion cells in the terminal hindgut, resulting in colonic dilatation, severe constipation, and obstruction. MEN 2A may also be associated with cutaneous lichen amyloidosis, which is a pruritic lichenoid lesion that is usually located on the upper back. MEN 2B, which is also referred to as MEN 3, represents 5% of all cases of MEN 2 and is"
        }
    ],
    "scores": [
        0.034898343206354765,
        0.026500638569604086,
        0.025932278762467443,
        0.023890387639748666,
        0.023739003937023738,
        0.022956352997300464,
        0.021492515045412358,
        0.0189318547193219,
        0.018874643874643875,
        0.018452380952380953,
        0.018362533692722373,
        0.017820370663709804,
        0.017745465916197627,
        0.017652928083506027,
        0.016522796358639267,
        0.0162569649295313,
        0.015640273704789834,
        0.01559109080525414,
        0.0155315232397607,
        0.014840299887028858,
        0.014023680124223602,
        0.013575490735644836,
        0.013435374149659864,
        0.01304639650977431,
        0.012644033717423247,
        0.012637362637362638,
        0.012420698616525262,
        0.01227409638554217,
        0.012043512043512044,
        0.01199859254046446,
        0.011898096304591266,
        0.011199601791936287
    ]
}